Critical Role of Macrophages and Their Activation via MyD88-NFκB Signaling in Lung Innate Immunity to Mycoplasma pneumoniae

Mycoplasma pneumoniae (Mp), a common cause of pneumonia, is associated with asthma; however, the mechanisms underlying this association remain unclear. We investigated the cellular immune response to Mp in mice. Intranasal inoculation with Mp elicited infiltration of the lungs with neutrophils, monocytes and macrophages. Systemic depletion of macrophages, but not neutrophils, resulted in impaired clearance of Mp from the lungs. Accumulation and activation of macrophages were decreased in the lungs of MyD88−/− mice and clearance of Mp was impaired, indicating that MyD88 is a key signaling protein in the anti-Mp response. MyD88-dependent signaling was also required for the Mp-induced activation of NFκB, which was essential for macrophages to eliminate the microbe in vitro. Thus, MyD88-NFκB signaling in macrophages is essential for clearance of Mp from the lungs.

[1]  Tonya S. King,et al.  A trial of clarithromycin for the treatment of suboptimally controlled asthma. , 2010, The Journal of allergy and clinical immunology.

[2]  H. Hakonarson,et al.  Recent advances in the genetics and genomics of asthma and related traits , 2010, Current opinion in pediatrics.

[3]  S. Abraham,et al.  New roles for mast cells in modulating allergic reactions and immunity against pathogens. , 2009, Current opinion in immunology.

[4]  C. Weaver,et al.  MMP induced by Gr‐1+ cells are crucial for recruitment of Th cells into the airways , 2009, European journal of immunology.

[5]  M. Ichinose,et al.  Oxidative stress augments toll-like receptor 8 mediated neutrophilic responses in healthy subjects , 2009, Respiratory research.

[6]  N. Van Rooijen,et al.  Mobilization and Margination of Bone Marrow Gr-1high Monocytes during Subclinical Endotoxemia Predisposes the Lungs toward Acute Injury1 , 2009, The Journal of Immunology.

[7]  S. Jeyaseelan,et al.  Neutrophil Recruitment to the Lungs during Bacterial Pneumonia , 2008, Infection and Immunity.

[8]  J. Frelinger,et al.  Infected-Host-Cell Repertoire and Cellular Response in the Lung following Inhalation of Francisella tularensis Schu S4, LVS, or U112 , 2008, Infection and Immunity.

[9]  K. Legge,et al.  Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs , 2008, The Journal of experimental medicine.

[10]  S. Weiland,et al.  Toll-like receptor heterodimer variants protect from childhood asthma. , 2008, The Journal of allergy and clinical immunology.

[11]  Stephen J. Galli,et al.  The development of allergic inflammation , 2008, Nature.

[12]  T. Strowig,et al.  Noncytotoxic Functions of NK Cells: Direct Pathogen Restriction and Assistance to Adaptive Immunity1 , 2008, The Journal of Immunology.

[13]  D. Vercelli,et al.  Discovering susceptibility genes for asthma and allergy , 2008, Nature Reviews Immunology.

[14]  E. R. Sutherland,et al.  Asthma and atypical bacterial infection. , 2007, Chest.

[15]  Shizuo Akira,et al.  Signaling to NF-?B by Toll-like receptors , 2007 .

[16]  Takashi Shimizu,et al.  Mycoplasma pneumoniae-Derived Lipopeptides Induce Acute Inflammatory Responses in the Lungs of Mice , 2007, Infection and Immunity.

[17]  M. Kronenberg,et al.  The unique role of natural killer T cells in the response to microorganisms , 2007, Nature Reviews Microbiology.

[18]  A. Bowie,et al.  The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling , 2007, Nature Reviews Immunology.

[19]  H. Marriott,et al.  THE ROLE OF THE MACROPHAGE IN LUNG DISEASE MEDIATED BY BACTERIA , 2007, Experimental lung research.

[20]  D. C. Krause,et al.  Terminal organelle development in the cell wall-less bacterium Mycoplasma pneumoniae , 2006, Proceedings of the National Academy of Sciences.

[21]  A. Mejias,et al.  Respiratory Tract Infection with Mycoplasma pneumoniae in Interleukin-12 Knockout Mice Results in Improved Bacterial Clearance and Reduced Pulmonary Inflammation , 2006, Infection and Immunity.

[22]  S. Akira,et al.  Toll-like receptor function and signaling. , 2006, The Journal of allergy and clinical immunology.

[23]  D. C. Krause,et al.  Synthesis, Stability, and Function of Cytadhesin P1 and Accessory Protein B/C Complex of Mycoplasma pneumoniae , 2006, Journal of bacteriology.

[24]  D. McDonald,et al.  Mast cells protect mice from Mycoplasma pneumonia. , 2006, American journal of respiratory and critical care medicine.

[25]  F. Brennan,et al.  Lung-marginated monocytes modulate pulmonary microvascular injury during early endotoxemia. , 2005, American journal of respiratory and critical care medicine.

[26]  Richard J Martin,et al.  TLR2 Signaling Is Critical for Mycoplasma pneumoniae-Induced Airway Mucin Expression1 , 2005, The Journal of Immunology.

[27]  A. Mejias,et al.  Mycoplasma pneumoniae induces host-dependent pulmonary inflammation and airway obstruction in mice. , 2005, American journal of respiratory cell and molecular biology.

[28]  Ken B. Waites,et al.  Mycoplasma pneumoniae and Its Role as a Human Pathogen , 2004, Clinical Microbiology Reviews.

[29]  K. Waites,et al.  Emerging intracellular bacterial infections. , 2004, Clinics in laboratory medicine.

[30]  D. Gendrel,et al.  Mycoplasma pneumoniae and asthma in children. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  Richard J Martin,et al.  Inhaled fluticasone propionate reduces concentration of Mycoplasma pneumoniae, inflammation, and bronchial hyperresponsiveness in lungs of mice. , 2004, The Journal of infectious diseases.

[32]  T. Shim,et al.  Dynamics of Macrophage Cell Populations During Murine Pulmonary Tuberculosis 1 , 2003, The Journal of Immunology.

[33]  H. Tomizawa,et al.  A novel structural class of potent inhibitors of NF-kappa B activation: structure-activity relationships and biological effects of 6-aminoquinazoline derivatives. , 2003, Bioorganic & medicinal chemistry.

[34]  R. Krause,et al.  Laboratory diagnosis of Mycoplasma pneumoniae infection. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[35]  H. Tomizawa,et al.  Discovery of quinazolines as a novel structural class of potent inhibitors of NF-κB activation , 2003 .

[36]  Kim Bottomly,et al.  Lipopolysaccharide-enhanced, Toll-like Receptor 4–dependent T Helper Cell Type 2 Responses to Inhaled Antigen , 2002, The Journal of experimental medicine.

[37]  Richard J Martin,et al.  Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. , 2002, Chest.

[38]  U. Yamashita,et al.  Reduced Expression of STAT4 and IFN-γ in Macrophages from BALB/c Mice1 , 2002, The Journal of Immunology.

[39]  F. Re,et al.  Toll-like Receptor 2 (TLR2) and TLR4 Differentially Activate Human Dendritic Cells* , 2001, The Journal of Biological Chemistry.

[40]  S. Akira,et al.  Toll-like receptors control activation of adaptive immune responses , 2001, Nature Immunology.

[41]  R. Martin,et al.  A link between chronic asthma and chronic infection. , 2001, The Journal of allergy and clinical immunology.

[42]  J. Just,et al.  Bacterial flora of the lower respiratory tract in children with bronchial asthma , 1999, Acta paediatrica.

[43]  H. Colten,et al.  Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. , 1999, Immunopharmacology.

[44]  S. Matalon,et al.  Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. A. Farmer,et al.  Mycoplasma pneumoniae Protein P30 Is Required for Cytadherence and Associated with Proper Cell Development , 1999, Journal of bacteriology.

[46]  H. Jafri,et al.  Mycoplasma pneumoniae pneumonia in a mouse model. , 1998, The Journal of infectious diseases.

[47]  R. Martin,et al.  Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. , 1998, American journal of respiratory and critical care medicine.

[48]  S. Akira,et al.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.

[49]  T. Mayadas,et al.  A Role for Mac-1 (CDIIb/CD18) in Immune Complex–stimulated Neutrophil Function In Vivo: Mac-1 Deficiency Abrogates Sustained Fcγ Receptor–dependent Neutrophil Adhesion and Complement-dependent Proteinuria in Acute Glomerulonephritis , 1997, The Journal of experimental medicine.

[50]  S. Michalek,et al.  Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasma-resistant C57BL mice but not mycoplasma-susceptible C3H mice , 1997, Infection and immunity.

[51]  S Askari,et al.  A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. , 1996, Immunity.

[52]  A. Chavoya,et al.  Biofunctional domains of the Mycoplasma pneumoniae P30 adhesin , 1996, Infection and immunity.

[53]  J. Lindsey,et al.  Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response , 1995, Infection and immunity.

[54]  N. Van Rooijen,et al.  Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. , 1994, Journal of immunological methods.

[55]  W. Quint,et al.  Genus- and species-specific identification of mycoplasmas by 16S rRNA amplification , 1993, Applied and environmental microbiology.

[56]  G. Tannock,et al.  Laboratory diagnosis of Mycoplasma pneumoniae infection. 4. Antigen capture and PCR-gene amplification for detection of the mycoplasma: problems of clinical correlation , 1992, Epidemiology and Infection.

[57]  A F Angulo,et al.  Genus- and species-specific identification of mycoplasmas by 16S rRNA amplification , 1992, Applied and environmental microbiology.

[58]  Susumu Tonegawa,et al.  RAG-1-deficient mice have no mature B and T lymphocytes , 1992, Cell.

[59]  Y. Naot,et al.  Mycoplasma pneumoniae is a frequent cause of exacerbation of bronchial asthma in adults. , 1986, Annals of allergy.

[60]  I. Mellman,et al.  Acidification of macrophage and fibroblast endocytic vesicles in vitro. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[61]  W. Wiktor-Jedrzejczak,et al.  Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation , 1982, The Journal of experimental medicine.

[62]  D. C. Krause,et al.  Molecular basis for cytadsorption of Mycoplasma pneumoniae , 1982, Journal of bacteriology.

[63]  D. C. Krause,et al.  Identification of Mycoplasma pneumoniae proteins associated with hemadsorption and virulence , 1982, Infection and immunity.

[64]  P. Elsbach,et al.  THE INTERACTION IN VITRO BETWEEN POLYMORPHONUCLEAR LEUKOCYTES AND MYCOPLASMA , 1971, The Journal of experimental medicine.

[65]  E. Benson,et al.  Laboratory diagnosis of Mycoplasma pneumoniae infection. , 1968, Postgraduate medicine.

[66]  S. Matalon,et al.  Surfactant dysfunction in SP-A-/- and iNOS-/- mice with mycoplasma infection. , 2007, American journal of respiratory cell and molecular biology.

[67]  S. Akira,et al.  TLR signaling. , 2006, Current topics in microbiology and immunology.

[68]  Yang Pc,et al.  (Am. J. Respir. Cell Mol. Biol., 32:540-547)Autocrine and Paracrine Regulation of IL-8 Expression in Lung Cancer Cells , 2005 .

[69]  I. Weissman,et al.  Flow cytometric identification of murine neutrophils and monocytes. , 1996, Journal of immunological methods.

[70]  J. C. Gil,et al.  Isolation of Mycoplasma pneumoniae from asthmatic patients. , 1993, Annals of allergy.

[71]  P. Skov,et al.  [Infections and asthma]. , 1986, Nordisk medicin.